Ruth Oren Hommonai
Chief Executive Officer presso INTER GAMMA INVESTMENT COMPANY LTD
Profilo
Ruth Oren Hommonai is currently the Chief Executive Officer at Inter-Gamma Investment Ltd.
She previously worked as the Director of the Legal Department at Dexcel Pharma Technologies Ltd.
Ms. Oren Hommonai graduated from Tel-Aviv University and holds an MBA from The Interdisciplinary Center Herzliya.
Posizioni attive di Ruth Oren Hommonai
| Società | Posizione | Inizio |
|---|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Chief Executive Officer | 01/01/2014 |
Precedenti posizioni note di Ruth Oren Hommonai
| Società | Posizione | Fine |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | General Counsel | - |
Formazione di Ruth Oren Hommonai
| Tel-Aviv University | Graduate Degree |
| The Interdisciplinary Center Herzliya | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Finance |
| Aziende private | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Borsa valori
- Insiders
- Ruth Oren Hommonai
